Chemed (CHE)
NYSE Market Closed
Chemed Corporation is a diversified operating company with two principal businesses: VITAS Healthcare and Roto-Rooter. Rather than functioning as a broad conglomerate with many unrelated holdings, Chemed is concentrated in two service-oriented segments that address very different but recurring needs in the US market: end-of-life healthcare and plumbing-related home and commercial services.
VITAS is the company’s largest revenue contributor and provides hospice and palliative care for patients with advanced or terminal illnesses. Its care model relies on interdisciplinary teams that may include physicians, nurses, home health aides, social workers, chaplains, and volunteers. Services are delivered in a variety of settings, including patients’ homes, nursing facilities, assisted living communities, hospitals, and dedicated inpatient hospice units. This segment is shaped by demographic trends, healthcare regulation, Medicare reimbursement, clinical staffing, and the ongoing preference for care outside traditional hospital settings.
Roto-Rooter gives Chemed a second, highly recognizable business in plumbing, drain cleaning, water cleanup, and related repair services. It serves both residential and commercial customers, responding to routine maintenance needs as well as urgent problems such as clogged drains, sewer line issues, and water damage. The brand’s national presence, service network, and emergency-response positioning are central to its competitive profile.
Chemed’s corporate approach is to own and operate businesses where cash generation, market position, and disciplined capital allocation can support long-term shareholder value. CHE therefore offers exposure to two distinct service markets: hospice care, driven by healthcare demand and aging demographics, and essential property services, driven by maintenance, repair, and emergency needs.
Last updated
- Market Cap
- 5.86B
- P/E
- 22.56
- P/FCF
- 15.54
- P/S
- 2.31
- Enterprise Value
- 5.94B
- Sector
- Health Care
- Industry
- Home Health Care Services
- Address
- SUITE 2600, CINCINNATI, OH, 45202
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Water Management Takes Centre Stage at Data Centre LIVE
Chemed Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Chemed Corporation to Present at the UBS 2025 Global Healthcare Conference
Chemed (CHE) Down 3.1% Since Last Earnings Report: Can It Rebound?
Should iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV) Be on Your Investing Radar?
EHC or CHE: Which Is the Better Value Stock Right Now?
Chemed (CHE) Q1 Earnings Miss Estimates
Here's Why You Should Retain Chemed (CHE) Stock for Now
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Chemed (CHE) Up 2.5% Since Last Earnings Report: Can It Continue?
Chemed (CHE) Reaches a New 52-Week High: What's Driving It?
Chemed's (CHE) VITAS Segment Inks New Deal With Covenant Care
Centene (CNC), Pearl Health Unite to Enhance Value-Based Care
Here's Why You Should Add Cigna (CI) Stock to Your Portfolio
Teladoc Health (TDOC) Unveils Solution to Ease Weight Loss
Should iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV) Be on Your Investing Radar?
Is Chemed (CHE) a Solid Growth Stock? 3 Reasons to Think "Yes"
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
ADUS vs. CHE: Which Stock Is the Better Value Option?
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 5.86B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 5.94B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 22.56
- P/B
P/B ratio compares a company's share price to its book value per share.
- 6.91
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 2.31
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 15.08
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 2.34
- EPS
- 19.57
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0.56%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 15.54
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 13.21
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 377.12M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 30.64%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 16.91%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.11
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0.85
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.83
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.05
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 244.3K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 441.59
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 657.51M | 639.34M | 624.9M | 618.8M | 646.94M |
| Gross profit | 215.76M | 225.17M | 196.91M | 184.69M | 216.41M |
| Operating income | 84.58M | 100.65M | 74.75M | 68.08M | 94.76M |
| EBITDA | 101.45M | 116.98M | 90.98M | 84.34M | 110.78M |
| Net income | 66.3M | 76.75M | 64.24M | 52.49M | 71.76M |
| Basic EPS | 4.85 | 5.45 | 4.46 | 3.6 | 4.91 |
| Diluted EPS | 4.84 | 5.45 | 4.46 | 3.57 | 4.86 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 1.54B | 1.54B | 1.62B | 1.72B | 1.73B |
| Total liabilities | 687.82M | 558.78M | 546.94M | 519.36M | 544.75M |
| Total equity | 847.99M | 979.41M | 1.08B | 1.2B | 1.18B |
| Cash & equivalents | 16.86M | 74.52M | 129.75M | 249.9M | 173.88M |
| Current assets | 274.06M | 302.62M | 395.24M | 491.38M | 502.39M |
| Current liabilities | 321.42M | 287.13M | 292.04M | 263.89M | 290.56M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 88.22M | 133.53M | 83.39M | 138.61M | 32.74M |
| Investing cash flow | -37.79M | -15.95M | -14.23M | -15.48M | -13.67M |
| Financing cash flow | -108.09M | -172.82M | -189.31M | -47.1M | -23.54M |
| Change in cash | -57.66M | -55.24M | -120.15M | 76.02M | -4.47M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — CHEMED CORP | View Filing | |
| form 4 | Form 4 — WALSH GEORGE J III | View Filing | |
| form 4 | Form 4 — WALSH GEORGE J III | View Filing | |
| edgar index | 8-K — CHEMED CORP | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — DeLyons Ron | View Filing | |
| form 4 | Form 4 — GRACE PATRICK P | View Filing | |
| form 4 | Form 4 — Heaney Christopher J | View Filing | |
| form 4 | Form 4 — LINDELL ANDREA R | View Filing | |
| form 4 | Form 4 — McCarthy Eileen P | View Filing | |
| form 4 | Form 4 — Mount John Meredith Jr. | View Filing | |
| form 4 | Form 4 — WALSH GEORGE J III | View Filing | |
| form 4 | Form 4 — WALSH GEORGE J III | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| edgar index | 144 — CHEMED CORP | View Filing | |
| form 4 | Form 4 — GRACE PATRICK P | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| edgar index | 144 — CHEMED CORP | View Filing | |
| edgar index | 144 — CHEMED CORP | View Filing | |
| form 4 | Form 4 — MCNAMARA KEVIN J | View Filing | |
| edgar index | SCHEDULE 13G — CHEMED CORP | View Filing | |
| edgar index | SCHEDULE 13G — CHEMED CORP | View Filing | |
| edgar index | 10-Q — CHEMED CORP | View Filing | |
| edgar index | 8-K — CHEMED CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — CHEMED CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEFR14A — CHEMED CORP | View Filing | |
| edgar index | DEF 14A — CHEMED CORP | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| edgar index | 144 — CHEMED CORP | View Filing | |
| form 4 | Form 4 — MCNAMARA KEVIN J | View Filing | |
| edgar index | SCHEDULE 13G/A — CHEMED CORP | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| edgar index | 144 — CHEMED CORP | View Filing | |
| edgar index | 144 — CHEMED CORP | View Filing | |
| form 4 | Form 4 — MCNAMARA KEVIN J | View Filing | |
| edgar index | 10-K — CHEMED CORP | View Filing | |
| edgar index | 8-K — CHEMED CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| edgar index | 4 — CHEMED CORP | View Filing | |
| form 4 | Form 4 — Judkins Brian C | View Filing | |
| form 4 | Form 4 — Judkins Brian C | View Filing | |
| form 4 | Form 4 — Judkins Brian C | View Filing | |
| form 4 | Form 4 — Judkins Brian C | View Filing | |
| form 4 | Form 4 — Judkins Brian C | View Filing | |
| form 4 | Form 4 — Judkins Brian C | View Filing | |
| form 4 | Form 4 — MCNAMARA KEVIN J | View Filing | |
| form 4 | Form 4 — MCNAMARA KEVIN J | View Filing | |
| form 4 | Form 4 — MCNAMARA KEVIN J | View Filing | |
| form 4 | Form 4 — MCNAMARA KEVIN J | View Filing | |
| form 4 | Form 4 — MCNAMARA KEVIN J | View Filing | |
| form 4 | Form 4 — MCNAMARA KEVIN J | View Filing | |
| form 4 | Form 4 — Witzeman Michael D | View Filing | |
| form 4 | Form 4 — Witzeman Michael D | View Filing | |
| form 4 | Form 4 — Witzeman Michael D | View Filing | |
| form 4 | Form 4 — Witzeman Michael D | View Filing | |
| form 4 | Form 4 — Witzeman Michael D | View Filing | |
| form 4 | Form 4 — Witzeman Michael D | View Filing | |
| form 4 | Form 4 — Wherley Joel L | View Filing | |
| form 4 | Form 4 — Wherley Joel L | View Filing | |
| form 4 | Form 4 — Wherley Joel L | View Filing | |
| form 4 | Form 4 — Wherley Joel L | View Filing |